🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
Mayo Clinic
Start Date
2002-09
Trial ID
NCT00047203
Treatments Being Tested
Phase I trial to study the effectiveness of combining flavopiridol, fluorou...
Status
Completed
Location
Mayo Clinic
Start Date
2001-05
Trial ID
NCT00021073
Treatments Being Tested
Phase II trial to study the effectiveness of flavopiridol in treating patie...
Status
Completed
Location
Cancer and Leukemia Group B
Start Date
1999-06
Trial ID
NCT00003620
Treatments Being Tested
Phase II trial to study the effectiveness of flavopiridol in treating patie...
Status
Completed
Location
Clinical Sciences Building
Start Date
1997-09
Trial ID
NCT00003039
Treatments Being Tested
Drugs used in chemotherapy use different ways to stop cancer cells from div...
Status
Completed
Location
COG Phase I Consortium
Start Date
2001-04
Trial ID
NCT00012181
Treatments Being Tested
This phase I trial is studying the side effects and best dose of flavopirid...
Status
Completed
Location
University of New Mexico
Start Date
2004-04
Trial ID
NCT00079352
Treatments Being Tested
The purpose of this two-stage Phase 2 study is to assess the clinical respo...
Status
Terminated
Location
Honor Health Research Institute
Start Date
2016-03-14
Trial ID
NCT02520011
Treatments Being Tested
Multicenter, open-label, study of alvocidib in previously treated chronic l...
Status
Completed
Location
Sanofi-Aventis Investigational Site Number 840008
Start Date
2007-03
Trial ID
NCT00464633
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Start Date
2003-06
Trial ID
NCT00064285
Treatments Being Tested
This phase I trial is studying the side effects and best dose of gemcitabin...
Status
Completed
Location
Massachusetts General Hospital Cancer Center
Start Date
2003-09
Trial ID
NCT00072436
Treatments Being Tested